Product
Hydroxy Urea
2 clinical trials
2 indications
Indication
Polycythemia VeraIndication
ThalassemiaClinical trial
Randomized, Open-label, Multicenter Phase 3 Study to Assess the Efficacy and Safety of GIVinostat Versus Hydroxyurea IN JAK2V617F-positive High-risk Polycythemia Vera Patients: the GIV-IN PV TRIALStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical TrialStatus: Recruiting, Estimated PCD: 2024-06-30